Labcorp and Waters Corporation are expanding flexible HPV screening options through a partnership that combines advanced virus detection with more convenient sample collection. The planned service will allow patients to access cervical cancer screening through healthcare facilities, patient service centers, or at-home collection, helping address barriers that prevent individuals from receiving recommended tests.
The BD Onclarity HPV Assay identifies six high-risk HPV types individually, alongside three grouped results, providing detailed information to support personalized risk assessments. Beginning in late 2026, Labcorp intends to introduce the FDA-approved test through its network of more than 2,200 patient service centers and 850,000 healthcare providers.
For Labcorp, the partnership could strengthen its women's health diagnostics offerings while reaching underserved populations. Waters may also benefit from broader distribution of its testing technology through an established nationwide laboratory network.
Image Credit: Waters Corporation / Labcorp
What's Driving This Trend
- At-home Diagnostics
- Home-based sample collection is reshaping preventive healthcare by reducing access barriers and expanding participation in routine screening programs.
- Personalized Risk Screening
- High-resolution HPV typing enables more precise patient stratification, creating new pathways for tailored follow-up care and early intervention models.
- Distributed Lab Access
- Nationwide service-center networks paired with advanced assays are making specialized diagnostics more accessible beyond traditional clinical settings.
Who This Affects Most
- Women’s Health
- Expanded cervical cancer screening options are strengthening women’s health services through more flexible, patient-centered testing models.
- Clinical Diagnostics
- Advanced molecular assays and broad laboratory infrastructure are accelerating the shift toward scalable, precision-based diagnostic services.
- Healthcare Access
- Convenient collection channels across homes, clinics, and service centers are creating new models for reaching underserved patient populations.
